CTVA Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

4.23B

+6.29%

0.212

-33.63%

4.64B

+5.1%

1.176

+4.04%

6.71B

+3.88%

2.306

+4.81%

Estimates Revision

The market is revising Upward the revenue expectations for Corteva, Inc. (CTVA) for FY2025, with the revenue forecasts being adjusted by 0.67% over the past three months. During the same period, the stock price has changed by 9.40%.

Revenue Estimates for FY2025

Revise Upward

+0.67%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+6.57%

In Past 3 Month

Stock Price

Go Up

+9.40%

In Past 3 Month

17 Analyst Rating

Wall Street analysts forecast CTVA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CTVA is 78.31 USD with a low forecast of 67.00 USD and a high forecast of 86.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

14 Buy

3 Hold

0 Sell

Strong Buy

Current: 0.000

Low

67.00

Averages

78.31

High

86.00

Current: 0.000

Low

67.00

Averages

78.31

High

86.00

BofA

Matthew DeYoe

Buy

maintain

$80 -> $82

2026-01-08

New

Reason

BofA

Matthew DeYoe

Price Target

$80 -> $82

2026-01-08

New

maintain

Buy

Reason

BofA analyst Matthew DeYoe raised the firm's price target on Corteva to $82 from $80 and keeps a Buy rating on the shares. The firm is updating its price targets for Chemicals under its coverage, the analyst tells investors. Commodities face another year of growing oversupply, specialties continue to manage an inconsistent backdrop, and agriculture presents a more mixed setup, the firm adds. BofA highlights that there are areas for optimism, with several possible catalysts for the stocks including PMI indicators shifting positive, rate cuts, and potential capacity rationalization in China. The firm cautions, however, that these catalysts are too new to rely on.

BWG Global

Mixed -> Positive

upgrade

2025-12-18

Reason

BWG Global

Price Target

2025-12-18

upgrade

Mixed -> Positive

Reason

BWG Global upgraded its view of Corteva to Positive from Mixed, citing checks pointing to an improved sales outlook.

Citi

Neutral

maintain

$68 -> $70

2025-12-18

Reason

Citi

Price Target

$68 -> $70

2025-12-18

maintain

Neutral

Reason

Citi raised the firm's price target on Corteva to $70 from $68 and keeps a Neutral rating on the shares. The firm updated estimates and targets in the chemicals group as part of its 2026 outlook. Citi is more negative on polyethylene producers and more positive on lithium fundamentals heading into next year.

Wells Fargo

Overweight

downgrade

$80 -> $77

2025-11-11

Reason

Wells Fargo

Price Target

$80 -> $77

2025-11-11

downgrade

Overweight

Reason

Wells Fargo assumed coverage of Corteva with an Overweight rating with a price target of $77, down from $80. The firm continues to believe in Corteva's ability to innovate and drive earnings growth, even as two separate companies.

Oppenheimer

Outperform

maintain

$75 -> $76

2025-11-07

Reason

Oppenheimer

Price Target

$75 -> $76

2025-11-07

maintain

Outperform

Reason

Oppenheimer raised the firm's price target on Corteva to $76 from $75 and keeps an Outperform rating on the shares. The firm remains constructive on shares of Corteva following a strong Q3 reminding investors why it has historically garnered a quality premium. Despite continued end-market challenges, the company delivered another beat-and-raise on strong volumes, execution against controllables, and comparatively dampened price pressures, Oppenheimer adds.

UBS

Buy

downgrade

$85 -> $81

2025-10-30

Reason

UBS

Price Target

$85 -> $81

2025-10-30

downgrade

Buy

Reason

UBS lowered the firm's price target on Corteva to $81 from $85 and keeps a Buy rating on the shares.

Valuation Metrics

The current forward P/E ratio for Corteva Inc (CTVA.N) is 19.94, compared to its 5-year average forward P/E of 20.14. For a more detailed relative valuation and DCF analysis to assess Corteva Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

20.14

Current PE

19.94

Overvalued PE

22.22

Undervalued PE

18.06

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

11.94

Current EV/EBITDA

11.88

Overvalued EV/EBITDA

13.05

Undervalued EV/EBITDA

10.84

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

2.27

Current PS

2.51

Overvalued PS

2.51

Undervalued PS

2.04

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

CTVA News & Events

Events Timeline

No data

News

7.5

01-07Benzinga

BP Forms 50:50 Joint Venture with Corteva to Produce Sustainable Aviation Fuel

7.5

01-07Newsfilter

Corteva and BP Launch Etlas Joint Venture to Produce 1 Million Tonnes of Biofuel Feedstocks Annually

9.5

01-06Newsfilter

Corteva Schedules Q4 2025 Earnings Release for February 3, 2026

People Also Watch

Frequently Asked Questions

What is Corteva Inc (CTVA) stock price today?

The current price of CTVA is 68.65 USD — it has decreased -2.12 % in the last trading day.

What is Corteva Inc (CTVA)'s business?

Corteva, Inc. is a global pure-play agriculture company. It is a global provider of seed and crop protection solutions focused on the agriculture industry and contributing to a healthier, secure and sustainable food supply. The Seed segment is engaged in developing and supplying commercial seed combining advanced germplasm and traits that produce optimum yield for farms around the world. It operates in various key seed markets, including North American corn and soybeans, European corn and sunflower, as well as Brazil, India, South Africa and Argentina corn. The Crop Protection segment serves the global agricultural input industry with products that protect against weeds, insects and other pests, and disease, and that support overall crop health both above and below ground via nitrogen management and seed-applied technologies. Its crop protection solutions and digital solutions provide farmers with tools to improve productivity and help keep fields free of weeds, insects and diseases.

What is the price predicton of CTVA Stock?

What is Corteva Inc (CTVA)'s revenue for the last quarter?

Corteva Inc revenue for the last quarter amounts to 2.62B USD, increased 12.55 % YoY.

What is Corteva Inc (CTVA)'s earnings per share (EPS) for the last quarter?

Corteva Inc. EPS for the last quarter amounts to -0.47 USD, decreased -38.16 % YoY.

What changes have occurred in the market's expectations for Corteva Inc (CTVA)'s fundamentals?

How many employees does Corteva Inc (CTVA). have?

Corteva Inc (CTVA) has 22000 emplpoyees as of January 10 2026.

What is Corteva Inc (CTVA) market cap?

Today CTVA has the market capitalization of 46.39B USD.